ArticlePharmacoEconomics - open2024

Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.

Gérard de Pouvourville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.